These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38874718)

  • 1. The Opioid Growth Factor in Growth Regulation and Immune Responses in Cancer.
    Hankins GR; Harris RT
    Adv Neurobiol; 2024; 35():45-85. PubMed ID: 38874718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell proliferation of human ovarian cancer is regulated by the opioid growth factor-opioid growth factor receptor axis.
    Donahue RN; McLaughlin PJ; Zagon IS
    Am J Physiol Regul Integr Comp Physiol; 2009 Jun; 296(6):R1716-25. PubMed ID: 19297547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B lymphocyte proliferation is suppressed by the opioid growth factor-opioid growth factor receptor axis: Implication for the treatment of autoimmune diseases.
    Zagon IS; Donahue RN; Bonneau RH; McLaughlin PJ
    Immunobiology; 2011; 216(1-2):173-83. PubMed ID: 20598772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of opioid growth factor (OGF) and opioid antagonist and their significance in cancer therapy.
    Wang R; Zhang Y; Shan F
    Int Immunopharmacol; 2019 Oct; 75():105785. PubMed ID: 31404891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth inhibition of thyroid follicular cell-derived cancers by the opioid growth factor (OGF) - opioid growth factor receptor (OGFr) axis.
    McLaughlin PJ; Zagon IS; Park SS; Conway A; Donahue RN; Goldenberg D
    BMC Cancer; 2009 Oct; 9():369. PubMed ID: 19835629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T lymphocyte proliferation is suppressed by the opioid growth factor ([Met(5)]-enkephalin)-opioid growth factor receptor axis: implication for the treatment of autoimmune diseases.
    Zagon IS; Donahue RN; Bonneau RH; McLaughlin PJ
    Immunobiology; 2011 May; 216(5):579-90. PubMed ID: 20965606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The opioid growth factor, [Met5]-enkephalin, and the zeta opioid receptor are present in human and mouse skin and tonically act to inhibit DNA synthesis in the epidermis.
    Zagon IS; Wu Y; McLaughlin PJ
    J Invest Dermatol; 1996 Mar; 106(3):490-7. PubMed ID: 8648182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid growth factor-opioid growth factor receptor axis is a physiological determinant of cell proliferation in diverse human cancers.
    Zagon IS; Donahue RN; McLaughlin PJ
    Am J Physiol Regul Integr Comp Physiol; 2009 Oct; 297(4):R1154-61. PubMed ID: 19675283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homeostasis of ocular surface epithelium in the rat is regulated by opioid growth factor.
    Zagon IS; Sassani JW; Kane ER; McLaughlin PJ
    Brain Res; 1997 Jun; 759(1):92-102. PubMed ID: 9219867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective oncotarget for gynecological cancer: Opioid growth factor (OGF) - opioid growth factor receptor (OGFr) axis.
    Qu N; Wang X; Meng Y; Shan F
    Int Immunopharmacol; 2019 Oct; 75():105723. PubMed ID: 31408839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid growth factor (OGF) inhibits anchorage-independent growth in human cancer cells.
    Zagon IS; McLaughlin PJ
    Int J Oncol; 2004 Jun; 24(6):1443-8. PubMed ID: 15138586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid growth factor tonically inhibits human colon cancer cell proliferation in tissue culture.
    Zagon IS; Hytrek SD; McLaughlin PJ
    Am J Physiol; 1996 Sep; 271(3 Pt 2):R511-8. PubMed ID: 8853370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of DNA synthesis of myocardial and epicardial cells in developing rat heart by [Met5]enkephalin.
    McLaughlin PJ
    Am J Physiol; 1996 Jul; 271(1 Pt 2):R122-9. PubMed ID: 8760212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid growth factor ([Met5]enkephalin) prevents the incidence and retards the growth of human colon cancer.
    Zagon IS; Hytrek SD; Lang CM; Smith JP; McGarrity TJ; Wu Y; McLaughlin PJ
    Am J Physiol; 1996 Sep; 271(3 Pt 2):R780-6. PubMed ID: 8853403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astrocyte proliferation is regulated by the OGF-OGFr axis in vitro and in experimental autoimmune encephalomyelitis.
    Campbell AM; Zagon IS; McLaughlin PJ
    Brain Res Bull; 2013 Jan; 90():43-51. PubMed ID: 22985690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid growth factor and the treatment of human pancreatic cancer: a review.
    Zagon IS; McLaughlin PJ
    World J Gastroenterol; 2014 Mar; 20(9):2218-23. PubMed ID: 24605021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid growth factor - opioid growth factor receptor axis inhibits proliferation of triple negative breast cancer.
    Zagon IS; Porterfield NK; McLaughlin PJ
    Exp Biol Med (Maywood); 2013 Jun; 238(6):589-99. PubMed ID: 23918871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human renal cell cancer proliferation in tissue culture is tonically inhibited by opioid growth factor.
    Bisignani GJ; McLaughlin PJ; Ordille SD; Beltz MS; Jarowenko MV; Zagon IS
    J Urol; 1999 Dec; 162(6):2186-91. PubMed ID: 10569617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The opioid growth factor-opioid growth factor receptor axis regulates cell proliferation of human hepatocellular cancer.
    Avella DM; Kimchi ET; Donahue RN; Tagaram HR; McLaughlin PJ; Zagon IS; Staveley-O'Carroll KF
    Am J Physiol Regul Integr Comp Physiol; 2010 Feb; 298(2):R459-66. PubMed ID: 19923357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination chemotherapy with gemcitabine and biotherapy with opioid growth factor (OGF) enhances the growth inhibition of pancreatic adenocarcinoma.
    Zagon IS; Jaglowski JR; Verderame MF; Smith JP; Leure-Dupree AE; McLaughlin PJ
    Cancer Chemother Pharmacol; 2005 Nov; 56(5):510-20. PubMed ID: 15947928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.